November 19, 2013
Yoanna Skrobik, MD, FRCPC; Intensivist, Hôpital Maisonneuve Rosemont, Montréal; Expert Panel for the new Pain, Sedation and Delirium Guidelines, Society of Critical Care Medline (SCCM) and selected teams from the Delirium Medication Reconciliation Collaborative.
Dr. Skrobik’s clinical research interests revolve primarily around critical care analgesia, sedation, and delirium. Specific areas include validating a novel delirium screening tool in mechanically ventilated patients in the ICU; the description of risk factors for developing ICU delirium; and comparing treatment modalities for the disorder. In addition, practice variability and assessment inconsistencies as well as multidisciplinary (nursing and physician) teaching initiatives in pain, sedation and delirium assessment interest her; she partners with the Canadian Collaborative in practice improvement projects. Dr. Skrobik was a task force member in the recently completed Society of Critical Care Medicine’s Pain, Anxiety, and Delirium management guidelines. Emerging projects include pharmacologic evaluation of analgesic and sedative drug effects.
Bruce Harries, Collaborative Director, Canadian ICU Collaborative
Paule Bernier, Nutritionist, Jewish General Hospital and SIA for Quebec Campaign (SHN)
Understanding when delirium can and cannot be assessed, and how sedatives make an accurate assessment more complicated
Understanding why different genetics, administering more than one drug or duration of sedative drug administration can change therapeutic effect and why it matters in the critically ill